Expert Joe DePinto analyzes the 2025 Cell and Gene Therapy Report, highlighting industry barriers and the growing role of oncologists in patient access.
Joe DePinto, MBA
Joe DePinto, MBA, is head of cell, gene, and advanced therapies at McKesson Pharmaceutical Solutions and Services.
Articles by Joe DePinto, MBA
Joe DePinto, MBA, discusses the complexity of the cell and gene therapy ecosystem and the need for collaboration with partners to support it effectively.
Joe DePinto, MBA, discusses some of the key challenges to equitable access to cell and gene therapies, especially in underserved populations.